/
Other
Cognition
54
Pipeline Programs↗
46
Active Trials↗
48
Companies Involved↗
Cognition is a moderately active landscape with 54 programs across 48 companies. The most active players are Otsuka, Harmony Biosciences Management, Inc.. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical48
Approved
No programs
Analysis
Modality Breakdown
98%
Small molecule
53 of 54 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 54 classified programs, each share of the total. Modality classified for 100% of 54 pipeline programs.
Analysis
Trial Status
218
clinical trials
Completed136 · 62%
Recruiting20 · 9%
Unknown status15 · 7%
Terminated14 · 6%
Not yet recruiting12 · 6%
Active, not recruiting11 · 5%
Other10 · 5%
Clinical Trials
Trial Activity
218 trials
Appetite and Cognition Response to a Breakfast Cereal
Recruiting·—·Preclinical·NCT07782229·184 enrolled
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
Recruiting·—·N/A·NCT03372317·105 enrolled
Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly
Recruiting·IInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta·N/A·NCT04841668·136 enrolled
Page 1 of 15
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)